540.18
price down icon0.10%   -0.7561
 
loading

Idexx Laboratories, Inc. Aktie (IDXX) Neueste Nachrichten

Private Advisor Group LLC Buys 261 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

pulisher
Defense World

IDEXX Laboratories (NASDAQ:IDXX) Price Target Cut to $596.00 by Analysts at Morgan Stanley - Defense World

pulisher
Defense World

IDEXX (IDXX) Aided by Global Growth, Solid Instrument Placement - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally

pulisher
Benzinga

Mitsubishi UFJ Asset Management Co. Ltd. Acquires 6,240 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

Those who invested in IDEXX Laboratories (NASDAQ:IDXX) five years ago are up 143% - Yahoo News Australia

pulisher
Yahoo News Australia

IDEXX Laboratories (NASDAQ:IDXX) Upgraded by StockNews.com to Buy - Defense World

pulisher
Defense World

IDEXX Laboratories (NASDAQ:IDXX) Upgraded to "Buy" at StockNews.com - MarketBeat

pulisher
MarketBeat

Unveiling IDEXX Laboratories (IDXX)'s Value: Is It Really Priced Right? A Comprehensive Guide - GuruFocus.com

pulisher
GuruFocus.com

IDEXX Labs jumps 8% on Q4 beat, up 44% since included in our stock strategy - MSN

pulisher
MSN

IDEXX Laboratories (NASDAQ:IDXX) Price Target Cut to $596.00 - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Torray Investment Partners LLC Reduces Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day - Business Wire

pulisher
Business Wire

Principal Securities Inc. Invests $875,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch

pulisher
MarketWatch

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives $580.88 Average PT from Brokerages - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

pulisher
Defense World

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Fisher Asset Management LLC - Defense World

pulisher
Defense World

Principal Financial Group Inc. Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store? - Yahoo Singapore News

pulisher
Yahoo Singapore News

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

IDEXX Laboratories Sees Leadership Transition and Shareholder Approval - TipRanks.com - TipRanks

pulisher
TipRanks

Here's Why You Should Retain IDEXX (IDXX) Stock for Now - MSN

pulisher
MSN

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Idexx Laboratories Breaks Above 200-Day Moving Average - Bullish for IDXX - Nasdaq

pulisher
Nasdaq

Geneva Capital Management LLC Has $31 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories (NASDAQ:IDXX) Knows How To Allocate Capital - Yahoo Finance

pulisher
Yahoo Finance

What Kind Of Shareholders Hold The Majority In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shares? - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Investing in IDEXX Laboratories (NASDAQ:IDXX) five years ago would have delivered you a 146% gain - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

Kestra Private Wealth Services LLC Buys 23 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

pulisher
Defense World

IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch

pulisher
MarketWatch

Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

43,518 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by TCG Advisory Services LLC - MarketBeat

pulisher
MarketBeat

William Blair Weighs in on IDEXX Laboratories, Inc.'s Q2 2024 Earnings (NASDAQ:IDXX) - Defense World

pulisher
Defense World

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - Yahoo Movies UK

pulisher
Yahoo Movies UK

Brokers Issue Forecasts for IDEXX Laboratories, Inc.'s Q2 2024 Earnings (NASDAQ:IDXX) - MarketBeat

pulisher
MarketBeat

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St

pulisher
Simply Wall St

William Blair Analysts Cut Earnings Estimates for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

pulisher
Defense World

IDEXX Laboratories, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next - Yahoo Finance

pulisher
Yahoo Finance

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

pulisher
MarketWatch

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

IDEXX Laboratories First Quarter 2024 Earnings: EPS Beats Expectations - Simply Wall St

pulisher
Simply Wall St

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance
diagnostics_research A
$154.48
price up icon 0.08%
diagnostics_research IQV
$231.44
price down icon 1.53%
diagnostics_research MTD
$1,509.40
price down icon 1.50%
$313.14
price down icon 0.84%
diagnostics_research WAT
$356.05
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):